Therapeutic Responses of Plasmodium vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar.
Chloroquine-primaquine (CQ-PQ) continues to be the frontline therapy for radical cure of Plasmodium vivax malaria. Emergence of CQ-resistant (CQR) P. vivax parasites requires shifting to artemisinin combination therapies (ACTs), which imposes a significant financial, logistical, and safety burden. M...
主要な著者: | Yuan, L, Wang, Y, Parker, D, Gupta, B, Yang, Z, Liu, H, Fan, Q, Cao, Y, Xiao, Y, Lee, M, Zhou, G, Yan, G, Baird, J, Cui, L |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2014
|
類似資料
-
Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
著者:: Baird, J, 等
出版事項: (1995) -
Therapeutic efficacy of chloroquine and primaquine for <it>Plasmodium vivax</it> malaria treatment in southeast Iran
著者:: Heidari Aliehsan, 等
出版事項: (2012-10-01) -
Comparison of the umulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in
Plasmodium vivax malaria
著者:: Chu, C, 等
出版事項: (2018) -
Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in plasmodium vivax malaria
著者:: Chu, C, 等
出版事項: (2018) -
Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial.
著者:: Xu, S, 等
出版事項: (2019)